Humacyte, Inc. (HUMA) P/B ratio

P/B ratio today
25.5×

Humacyte, Inc. (HUMA) trades at 25.5× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 48.9×. Today's figure is 47.9% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 11:43 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/B ratio today
25.5×
P/B ratio, fiscal 2025
48.9×
Highest on record
48.9×fiscal 2025
Lowest on record
1.9×fiscal 2022
Fiscal years on record
32022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Humacyte, Inc. P/B ratio, in more detail

Across the 3 fiscal year-ends on record (2022–2025), the highest was 48.9× in fiscal 2025 and the lowest 1.9× in fiscal 2022. Today's P/B ratio is higher than at 67% of the 3 fiscal year-ends on record; their median is 21.7×.

History · 3 fiscal years

P/B ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Humacyte, Inc. P/B ratio, year by year

Humacyte, Inc. (HUMA) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today25.5×—$0.50—
202548.9×—$0.96$0.02
2024——$5.05-$0.44
202321.7× 1,066.0% up$2.84$0.13
20221.9×—$2.11$1.13
2021——$7.25—
2020——$10.17—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

More on HUMA

Humacyte, Inc., figure by figure

Humacyte, Inc. (HUMA) overview: price, valuation and scorecard

Humacyte, Inc. P/B ratio: questions and answers

What is Humacyte, Inc.'s P/B ratio?

Humacyte, Inc. (HUMA) trades at 25.5× its book value per share at the end of fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/B ratio was 48.9×.

Is Humacyte, Inc.'s P/B ratio high or low compared with its own history?

Today's P/B ratio is higher than at 67% of the 3 fiscal year-ends on record; their median is 21.7×.

What are the highest and lowest P/B ratio figures on record for Humacyte, Inc.?

Across the 3 fiscal year-ends on record (2022–2025), the highest was 48.9× in fiscal 2025 and the lowest 1.9× in fiscal 2022.

How is Humacyte, Inc.'s P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B. For Humacyte, Inc. it is on record here for 3 fiscal years, 2022 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Humacyte, Inc. (HUMA) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/HUMA/pb-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.